Blue-hued virus image


1. Aibibula W, Cox J, Hamelin AM, Mamiya H, Klein MB, Brassard P. 2016. Food insecurity and low CD4 count among HIV-infected people: a systematic review and meta-analysis. AIDS Care 28:1577-1585.

2. Ajamian L, Melnychuk L, Jean-Pierre P, Zaharatos GJ. 2018. DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity. Viruses 10.

3. Almeida-Brasil CC, Moodie EEM, McLinden T, Hamelin AM, Walmsley SL, Rourke SB, Wong A, Klein MB, Cox J. 2018. Medication nonadherence, multitablet regimens, and food insecurity are key experiences in the pathway to incomplete HIV suppression. AIDS 32:1323-1332.

4. Alpuche-Lazcano SP, McCullogh CR, Del Corpo O, Rance E, Scarborough RJ, Mouland AJ, Sagan SM, Teixeira MM, Gatignol A. 2018. Higher Cytopathic Effects of a Zika Virus Brazilian Isolate from Bahia Compared to a Canadian-Imported Thai Strain. Viruses 10.

5. Amador-Canizares Y, Bernier A, Wilson JA, Sagan SM. 2018. miR-122 does not impact recognition of the HCV genome by innate sensors of RNA but rather protects the 5' end from the cellular pyrophosphatases, DOM3Z and DUSP11. Nucleic Acids Res 46:5139-5158.

6. Asundi A, Beliavsky A, Liu XJ, Akaberi A, Schwarzer G, Bisoffi Z, Requena-Mendez A, Shrier I, Greenaway C. 2019. Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis. Lancet Glob Health 7:e236-e248.

7. Baxter AE, Niessl J, Fromentin R, Richard J, Porichis F, Massanella M, Brassard N, Alsahafi N, Routy JP, Finzi A, Chomont N, Kaufmann DE. 2017. Multiparametric characterization of rare HIV-infected cells using an RNA-flow FISH technique. Nat Protoc 12:2029-2049.

8. Beitari S, Ding S, Pan Q, Finzi A, Liang C. 2017. Effect of HIV-1 Env on SERINC5 Antagonism. J Virol 91.

9. Bekker LG, Alleyne G, Baral S, Cepeda J, Daskalakis D, Dowdy D, Dybul M, Eholie S, Esom K, Garnett G, Grimsrud A, Hakim J, Havlir D, Isbell MT, Johnson L, Kamarulzaman A, Kasaie P, Kazatchkine M, Kilonzo N, Klag M, Klein M, Lewin SR, Luo C, Makofane K, Martin NK, Mayer K, Millett G, Ntusi N, Pace L, Pike C, Piot P, Pozniak A, Quinn TC, Rockstroh J, Ratevosian J, Ryan O, Sippel S, Spire B, Soucat A, Starrs A, Strathdee SA, Thomson N, Vella S, Schechter M, Vickerman P, Weir B, Beyrer C. 2018. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission. Lancet 392:312-358.

10. Benmassaoud A, Nitulescu R, Pembroke T, Halme AS, Ghali P, Deschenes M, Wong P, Klein MB, Sebastiani G. 2018. Liver-related events in HIV-infected persons with occult cirrhosis. Clin Infect Dis doi:10.1093/cid/ciy1082.

11. Brenner BG, Baril JG. 2017. Limiting cardiovascular events associated with HIV and antiretroviral therapy. AIDS 31:2551-2553.

12. Brenner BG, Thomas R, Blanco JL, Ibanescu RI, Oliveira M, Mesplede T, Golubkov O, Roger M, Garcia F, Martinez E, Wainberg MA. 2016. Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors. J Antimicrob Chemother 71:1948-1953.

13. Brouillette MJ, Fellows LK, Finch L, Thomas R, Mayo NE. 2019. Properties of a brief assessment tool for longitudinal measurement of cognition in people living with HIV. PLoS One 14:e0213908.

14. Brunet L, Moodie EEM, Young J, Cox J, Hull M, Cooper C, Walmsley S, Martel-Laferriere V, Rachlis A, Klein MB, Canadian Co-infection Cohort S, Cohen J, Conway B, Cooper C, Cote P, Cox J, Gill J, Haider S, Sadr A, Johnston L, Hull M, Montaner J, Moodie E, Pick N, Rachlis A, Rouleau D, Sandre R, Tyndall JM, Vachon ML, Sanche S, Skinner S, Wong D. 2016. Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected Persons. Clin Infect Dis 62:242-249.

15. Chahal J, Gebert LFR, Gan HH, Camacho E, Gunsalus KC, MacRae IJ, Sagan SM. 2019. miR-122 and Ago interactions with the HCV genome alter the structure of the viral 5' terminus. Nucleic Acids Res doi:10.1093/nar/gkz194.

16. Cinti A, Le Sage V, Ghanem M, Mouland AJ. 2016. HIV-1 Gag Blocks Selenite-Induced Stress Granule Assembly by Altering the mRNA Cap-Binding Complex. MBio 7:e00329.

17. Cinti A, Le Sage V, Milev MP, Valiente-Echeverria F, Crossie C, Miron MJ, Pante N, Olivier M, Mouland AJ. 2017. HIV-1 enhances mTORC1 activity and repositions lysosomes to the periphery by co-opting Rag GTPases. Sci Rep 7:5515.

18. Daher J, Vijh R, Linthwaite B, Dave S, Kim J, Dheda K, Peter T, Pai NP. 2017. Do digital innovations for HIV and sexually transmitted infections work? Results from a systematic review (1996-2017). BMJ Open 7:e017604.

19. Danchuk SN, McIntosh F, Jamieson FB, May K, Behr MA. 2019. Bacillus Calmette-Guerin strains with defined resistance mutations: a new tool for tuberculosis laboratory quality control. Clin Microbiol Infect doi:10.1016/j.cmi.2019.10.033.

20. Denault JS, Cabot JF, Langlois H, Marcotte S, Sheehan NL. 2019. Optimizing concentrations of concomitant antiretrovirals by reducing etravirine doses: two case reports of complex drug-drug interactions. Antivir Ther 24:73-76.

21. Dupuy FP, Kant S, Barbe A, Routy JP, Bruneau J, Lebouche B, Tremblay C, Pazgier M, Finzi A, Bernard NF. 2019. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects. mBio 10.

22. de Pokomandy A, Burchell AN, Salters K, Ding E, O'Brien N, Bakombo DM, Proulx-Boucher K, Boucoiran I, Pick N, Ogilvie G, Loutfy M, Kaida A, Team CR. 2019. Cervical cancer screening among women living with HIV: a cross-sectional study using the baseline questionnaire data from the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS). CMAJ Open 7:E217-E226.

23. Engler K, Lenart A, Lessard D, Toupin I, Lebouche B. 2018. Barriers to antiretroviral therapy adherence in developed countries: a qualitative synthesis to develop a conceptual framework for a new patient-reported outcome measure. AIDS Care 30:17-28.

24. Fava VM, Dallmann-Sauer M, Schurr E. 2019. Genetics of leprosy: today and beyond. Hum Genet doi:10.1007/s00439-019-02087-5.

25. Fava VM, Xu YZ, Lettre G, Van Thuc N, Orlova M, Thai VH, Tao S, Croteau N, Eldeeb MA, MacDougall EJ, Cambri G, Lahiri R, Adams L, Fon EA, Trempe JF, Cobat A, Alcais A, Abel L, Schurr E. 2019. Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson's disease. Proc Natl Acad Sci U S A 116:15616-15624.

26. Ghadaki B, Kronfli N, Vanniyasingam T, Haider S. 2016. Chronic obstructive pulmonary disease and HIV: are we appropriately screening? AIDS Care 28:1338-1343.

27. Hankins C, Warren M, Njeuhmeli E. 2016. Voluntary Medical Male Circumcision for HIV Prevention: New Mathematical Models for Strategic Demand Creation Prioritizing Subpopulations by Age and Geography. PLoS One 11:e0160699.

28. Hendin HE, Pillet S, Lara AN, Wu CY, Charland N, Landry N, Ward BJ. 2017. Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro. Vaccine 35:2592-2599.

29. Heywood AE, Castelli F, Greenaway C. 2019. Migration Health: Highlights from Inaugural International Society of Travel Medicine (ISTM) Conference on Migration Health. Curr Infect Dis Rep 21:48.

30. Jubran B, Billick M, Devlin G, Cygler J, Lebouche B. 2016. Reevaluating Canada's policy for blood donations from men who have sex with men (MSM). J Public Health Policy 37:428-439.

31. Kiani Z, Dupuy FP, Bruneau J, Lebouche B, Retiere C, Geraghty DE, Bernard NF. 2019. The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells. J Virol 93.

32. Kirakoya-Samadoulougou F, Jean K, Maheu-Giroux M. 2017. Uptake of HIV testing in Burkina Faso: an assessment of individual and community-level determinants. BMC Public Health 17:486.

33. Kronfli N, Bhatnagar SR, Hull MW, Moodie EEM, Cox J, Walmsley S, Gill J, Cooper C, Martel-Laferriere V, Pick N, Klein MB, Canadian Co-Infection Cohort I. 2019. Trends in cause-specific mortality in HIV-hepatitis C coinfection following hepatitis C treatment scale-up. AIDS 33:1013-1022.

34. Kronfli N, Lacombe-Duncan A, Wang Y, de Pokomandy A, Kaida A, Logie C, Conway T, Kennedy VL, Burchell A, Tharao W, Pick N, Kestler M, Sereda P, Loutfy M, On Behalf Of The Chiwos Research T. 2017. Access and engagement in HIV care among a national cohort of women living with HIV in Canada. AIDS Care 29:1235-1242.

35. Kronfli N, Linthwaite B, Kouyoumdjian F, Klein MB, Lebouche B, Sebastiani G, Cox J. 2018. Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review. Int J Drug Policy 57:95-103.

36. Kucharski TJ, Minshall PE, Moustafa-Kamal M, Turnell AS, Teodoro JG. 2017. Reciprocal Regulation between 53BP1 and the Anaphase-Promoting Complex/Cyclosome Is Required for Genomic Stability during Mitotic Stress. Cell Rep 18:1982-1995.

37. Lam A, Mayo NE, Scott S, Brouillette MJ, Fellows LK. 2019. HIV-Related Stigma Affects Cognition in Older Men Living With HIV. J Acquir Immune Defic Syndr 80:198-204.

38. Lee RS, Proulx JF, McIntosh F, Behr MA, Hanage WP. 2020. Previously undetected super-spreading of Mycobacterium tuberculosis revealed by deep sequencing. Elife 9.


39. Lessard D, Engler K, Toupin I, Team ISC, Routy JP, Lebouche B. 2019. Evaluation of a project to engage patients in the development of a patient-reported measure for HIV care (the I-Score Study). Health Expect 22:209-225.

40. Liu Y, Goulet ML, Sze A, Hadj SB, Belgnaoui SM, Lababidi RR, Zheng C, Fritz JH, Olagnier D, Lin R. 2016. RIG-I-Mediated STING Upregulation Restricts Herpes Simplex Virus 1 Infection. J Virol 90:9406-9419.

41. Maheu-Giroux M, Vesga JF, Diabate S, Alary M, Baral S, Diouf D, Abo K, Boily MC. 2017. Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Cote d'Ivoire: Insights from mathematical modeling. PLoS Med 14:e1002321.

42. Mancini M, Caignard G, Charbonneau B, Dumaine A, Wu N, Leiva-Torres GA, Gerondakis S, Pearson A, Qureshi ST, Sladek R, Vidal SM. 2019. Rel-Dependent Immune and Central Nervous System Mechanisms Control Viral Replication and Inflammation during Mouse Herpes Simplex Encephalitis. J Immunol 202:1479-1493.

43. Mayo NE, Brouillette MJ, Fellows LK. 2018. Estimates of Prevalence of Cognitive Impairment From Research Studies Can Be Affected by Selection Bias. J Acquir Immune Defic Syndr 78:e7-e8.

44. Mayo NE, Brouillette MJ, Fellows LK, Positive Brain Health Now I. 2016. Understanding and optimizing brain health in HIV now: protocol for a longitudinal cohort study with multiple randomized controlled trials. BMC Neurol 16:8.

45. McLinden T, Moodie EEM, Hamelin AM, Harper S, Walmsley SL, Paradis G, Aibibula W, Klein MB, Cox J. 2017. Injection Drug Use, Unemployment, and Severe Food Insecurity Among HIV-HCV Co-Infected Individuals: A Mediation Analysis. AIDS Behav 21:3496-3505.

46. Mehraj V, Ramendra R, Isnard S, Dupuy FP, Lebouche B, Costiniuk C, Thomas R, Szabo J, Baril JG, Trottier B, Cote P, LeBlanc R, Durand M, Chartrand-Lefebvre C, Kema I, Zhang Y, Finkelman M, Tremblay C, Routy JP. 2019. CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection. Front Immunol 10:289.

47. Melnychuk L, Ajamian L, Jean-Pierre P, Liang J, Gheorghe R, Wainberg MA, Zaharatos GJ. 2017. Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region. Vaccine 35:2736-2744.

48. Mesplede T, Leng J, Pham HT, Liang J, Quan Y, Han Y, Wainberg MA. 2017. The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration. MBio 8.

49. Morita M, Prudent J, Basu K, Goyon V, Katsumura S, Hulea L, Pearl D, Siddiqui N, Strack S, McGuirk S, St-Pierre J, Larsson O, Topisirovic I, Vali H, McBride HM, Bergeron JJ, Sonenberg N. 2017. mTOR Controls Mitochondrial Dynamics and Cell Survival via MTFP1. Mol Cell 67:922-935 e925.

50. Morita M, Siddiqui N, Katsumura S, Rouya C, Larsson O, Nagashima T, Hekmatnejad B, Takahashi A, Kiyonari H, Zang M, St-Arnaud R, Oike Y, Giguere V, Topisirovic I, Okada-Hatakeyama M, Yamamoto T, Sonenberg N. 2019. Hepatic posttranscriptional network comprised of CCR4-NOT deadenylase and FGF21 maintains systemic metabolic homeostasis. Proc Natl Acad Sci U S A doi:10.1073/pnas.1816023116.

51. Morris BJ, Hankins CA. 2017. Effect of male circumcision on risk of sexually transmitted infections and cervical cancer in women. Lancet Glob Health 5:e1054-e1055.

52. Njeuhmeli E, Schnure M, Vazzano A, Gold E, Stegman P, Kripke K, Tchuenche M, Bollinger L, Forsythe S, Hankins C. 2019. Using mathematical modeling to inform health policy: A case study from voluntary medical male circumcision scale-up in eastern and southern Africa and proposed framework for success. PLoS One 14:e0213605.

53. O'Brien N, Hong QN, Law S, Massoud S, Carter A, Kaida A, Loutfy M, Cox J, Andersson N, de Pokomandy A. 2018. Health System Features That Enhance Access to Comprehensive Primary Care for Women Living with HIV in High-Income Settings: A Systematic Mixed Studies Review. AIDS Patient Care STDS 32:129-148.

54. Olagnier D, Lababidi RR, Hadj SB, Sze A, Liu Y, Naidu SD, Ferrari M, Jiang Y, Chiang C, Beljanski V, Goulet ML, Knatko EV, Dinkova-Kostova AT, Hiscott J, Lin R. 2017. Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity. Mol Ther 25:1900-1916.

55. Osman N, Mesplede T, Oliveira M, Hassounah S, Wainberg MA, Brenner BG. 2018. Durable suppression of HIV-1 with resistance mutations to integrase inhibitors by dolutegravir following drug washout. AIDS 32:1773-1780.

56. Ostergaard L, Vesikari T, Absalon J, Beeslaar J, Ward BJ, Senders S, Eiden JJ, Jansen KU, Anderson AS, York LJ, Jones TR, Harris SL, O'Neill R, Radley D, Maansson R, Pregaldien JL, Ginis J, Staerke NB, Perez JL, B, Investigators BT. 2017. A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults. N Engl J Med 377:2349-2362.

57. Pai NP, Smallwood M, Gulati D, Lapczak N, Musten A, Gaydos C, Johnston C, Steben M, Wong T, Engel N, Kim J. 2018. What do Key Stakeholders Think About HIV Self-Testing in Canada? Results from a Cross-Sectional Survey. AIDS Behav 22:606-615.

58. Pardy RD, Rajah MM, Condotta SA, Taylor NG, Sagan SM, Richer MJ. 2017. Analysis of the T Cell Response to Zika Virus and Identification of a Novel CD8+ T Cell Epitope in Immunocompetent Mice. PLoS Pathog 13:e1006184.

59. Pardy RD, Richer MJ. 2019. Zika Virus Pathogenesis: From Early Case Reports to Epidemics. Viruses 11.

60. Radetskyy R, Daher A, Gatignol A. 2018. ADAR1 and PKR, interferon stimulated genes with clashing effects on HIV-1 replication. Cytokine Growth Factor Rev 40:48-58.

61. Ramendra R, Isnard S, Mehraj V, Chen J, Zhang Y, Finkelman M, Routy JP. 2019. Circulating LPS and (1-->3)-beta-D-Glucan: A Folie a Deux Contributing to HIV-Associated Immune Activation. Front Immunol 10:465.

62. Rao S, Amorim R, Niu M, Breton Y, Tremblay MJ, Mouland AJ. 2019. Host mRNA decay proteins influence HIV-1 replication and viral gene expression in primary monocyte-derived macrophages. Retrovirology 16:3.

63. Robichaud N, Hsu BE, Istomine R, Alvarez F, Blagih J, Ma EH, Morales SV, Dai DL, Li G, Souleimanova M, Guo Q, Del Rincon SV, Miller WH, Jr., Ramon YCS, Park M, Jones RG, Piccirillo CA, Siegel PM, Sonenberg N. 2018. Translational control in the tumor microenvironment promotes lung metastasis: Phosphorylation of eIF4E in neutrophils. Proc Natl Acad Sci U S A 115:E2202-E2209.

64. Rolle CP, Rosenberg ES, Siegler AJ, Sanchez TH, Luisi N, Weiss K, Cutro S, Del Rio C, Sullivan PS, Kelley CF. 2017. Challenges in Translating PrEP Interest Into Uptake in an Observational Study of Young Black MSM. J Acquir Immune Defic Syndr 76:250-258.

65. Rosenberg ES, Doyle K, Munoz-Jordan JL, Klein L, Adams L, Lozier M, Weiss K, Sharp TM, Paz-Bailey G. 2018. Prevalence and incidence of Zika virus infection among household contacts of patients with Zika virus disease, Puerto Rico, 2016-2017. J Infect Dis doi:10.1093/infdis/jiy689.

66. Rossi C, Saeed S, Cox J, Vachon ML, Martel-Laferriere V, Walmsley SL, Cooper C, Gill MJ, Hull M, Moodie EEM, Klein MB, Canadian Co-Infection Cohort I. 2018. Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients. AIDS 32:751-759.

67. Schafer IB, Yamashita M, Schuller JM, Schussler S, Reichelt P, Strauss M, Conti E. 2019. Molecular Basis for poly(A) RNP Architecture and Recognition by the Pan2-Pan3 Deadenylase. Cell 177:1619-1631 e1621.

68. Schweitzer L, Singh B, Rupali P, Libman M. 2019. Emerging concepts in the diagnosis, treatment, and prevention of travelers' diarrhea. Curr Opin Infect Dis 32:468-474.

69. Shapiro JR, Hodgins B, Hendin HE, Patel A, Menassa K, Menassa C, Menassa M, Pereira JA, Ward BJ. 2019. Needle-free delivery of influenza vaccine using the Med-Jet(R) H4 is efficient and elicits the same humoral and cellular responses as standard IM injection: A randomized trial. Vaccine 37:1332-1339.

70. Smith LK, Boukhaled GM, Condotta SA, Mazouz S, Guthmiller JJ, Vijay R, Butler NS, Bruneau J, Shoukry NH, Krawczyk CM, Richer MJ. 2018. Interleukin-10 Directly Inhibits CD8(+) T Cell Function by Enhancing N-Glycan Branching to Decrease Antigen Sensitivity. Immunity 48:299-312 e295.

71. Stewart JIP, Fava VM, Kerkaert JD, Subramanian AS, Gravelat FN, Lehoux M, Howell PL, Cramer RA, Sheppard DC. 2020. Reducing Aspergillus fumigatus Virulence through Targeted Dysregulation of the Conidiation Pathway. mBio 11.

72. Strauss M, Schotte L, Karunatilaka KS, Filman DJ, Hogle JM. 2017. Cryo-electron Microscopy Structures of Expanded Poliovirus with VHHs Sample the Conformational Repertoire of the Expanded State. J Virol 91.

73. Tavitian-Exley I, Boily MC, Heimer R, Uuskula A, Levina O, Maheu-Giroux M. 2018. Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis. AIDS Behav 22:1329-1340.

74. Vuille-Lessard E, Lebouche B, Lennox L, Routy JP, Costiniuk CT, Pexos C, Giannakis A, Szabo J, Klein MB, Sebastiani G. 2016. Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients. AIDS 30:2635-2643.

75. Wang Z, Pan Q, Gendron P, Zhu W, Guo F, Cen S, Wainberg MA, Liang C. 2016. CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape. Cell Rep 15:481-489.

76. Xu B, Pan Q, Liang C. 2018. Role of MxB in Alpha Interferon-Mediated Inhibition of HIV-1 Infection. J Virol 92.

77. Yang L, Wang L, Ketkar H, Ma J, Yang G, Cui S, Geng T, Mordue DG, Fujimoto T, Cheng G, You F, Lin R, Fikrig E, Wang P. 2018. UBXN3B positively regulates STING-mediated antiviral immune responses. Nat Commun 9:2329.

78. Young J, Rossi C, Gill J, Walmsley S, Cooper C, Cox J, Martel-Laferriere V, Conway B, Pick N, Vachon ML, Klein MB, Canadian Co-infection Cohort I. 2017. Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV. Clin Infect Dis 64:1154-1162.

79. Younger J, Raboud J, Szadkowski L, Harrigan R, Walmsley S, Bayoumi AM, Klein MB, Cooper C, Burchell AN, Loutfy M, Hull M, Wong A, Thomas R, Hogg R, Montaner J, Tsoukas C, Antoniou T, Canadian Observational Cohort C. 2019. Tenofovir and emtricitabine resistance among antiretroviral-naive patients in the Canadian Observational Cohort Collaboration: implications for PrEP. Antivir Ther doi:10.3851/IMP3302.

80. Yuki KE, Marei H, Fiskin E, Eva MM, Gopal AA, Schwartzentruber JA, Majewski J, Cellier M, Mandl JN, Vidal SM, Malo D, Dikic I. 2019. CYRI/FAM49B negatively regulates RAC1-driven cytoskeletal remodelling and protects against bacterial infection. Nat Microbiol 4:1516-1531.

81. Zacharias CA, Sheppard DC. 2019. The role of Aspergillus fumigatus polysaccharides in host-pathogen interactions. Curr Opin Microbiol 52:20-26.

Back to top